Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis.
NF-κB
PARP
RAS
cancer
oncogenes
Journal
Cancer investigation
ISSN: 1532-4192
Titre abrégé: Cancer Invest
Pays: England
ID NLM: 8307154
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
pubmed:
24
1
2020
medline:
10
5
2020
entrez:
24
1
2020
Statut:
ppublish
Résumé
Cancer is a multi-step process during which cells acquire mutations that eventually lead to uncontrolled cell growth and division and evasion of programmed cell death. The oncogenes such as Ras and c-Myc may be responsible in all three major stages of cancer i.e., early, intermediate, and late. The NF-κB has been shown to control the expression of genes linked with tumor pathways such as chronic inflammation, tumor cell survival, anti-apoptosis, proliferation, invasion, and angiogenesis. In the last few decades, various biomarker pathways have been identified that play a critical role in carcinogenesis such as Ras, NF-κB and DNA damage.
Identifiants
pubmed: 31971023
doi: 10.1080/07357907.2020.1721523
doi:
Substances chimiques
NF-kappa B
0
ras Proteins
EC 3.6.5.2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM